Outsourcing Outlook

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-08-01-2001, Volume 2001 Supplement, Issue 2

The consolidation of the contract manufacturing industry has spread to the parenteral fill-finish segment, with two deals announced just before this year's Fourth of July holiday.

Related Content:

Bio/Pharma BusinessOutsourcingOutsourcing OutlookContract Manufacturing, GeneralPharmaceutical Technology-08-01-2001
Alentis Therapeutics to Advance Anti-Claudin-1 ADCs to Treat Solid Tumors on $181.4 Million Financing
Avantor Sees Future of Opportunities with Growing Development of Next-Gen Biotherapeutics
Merck and Ginkgo Bioworks’ Collaboration to Improve Biologics Manufacturing Has Reached Its First Milestone